-
Document de presse | 2021.05.21
ART Plus Combination Immunotherapy Expands Natural Killer Cells That Facilitate Control of HIV
Yerkes National Primate Research Center researchers in collaboration with Institut Pasteur have determined a combination immunotherapy of Interleukin-21 (IL-21) and interferon alpha (IFNa) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models. This finding is key for controlling HIV/AIDS, which...
-
News | 2022.06.14
A New Drug Target against Malaria
Malaria is a disease that continues to cause tremendous suffering and mortality in the tropics. This disease is caused by Plasmodium parasites. The species Plasmodium falciparum causes the severest and most deadly form of malaria. Scientists from Institut Pasteur studied the blood stage of the parasites and found a mechanism which could lead to new and efficient drugs against Malaria.Despite...
-
Article | 2024.04.30
Charles Chamberland, the inventor of sterilization tools
Physicist and biologist Charles Chamberland was one of Louis Pasteur’s earliest associates. Associated with much of his tutor’s work, he was also a great inventor, designing an autoclave and a water filter, which are both named after him.
-
Portrait | 2024.06.28
Mathieu Picardeau: tackling the trio of water, rats and leptospirosis
Mathieu Picardeau is Head of the Biology of Spirochetes Unit and the National Reference Center for Leptospirosis at the Institut Pasteur. Mathieu is warm, friendly and well-read, with a passion for contemporary art in his free time – but what really gets him excited is a very specific family of bacteria, some of which are fatal for humans. Despite his many responsibilities, he spends time in the...
-
Portrait | 2024.11.18
Morgane Besson: alcohol, smoking, cocaine – are we equal when it comes to addiction?
Tobacco, alcohol, cocaine – addictive substances are responsible for multiple health problems. Neurobiology researcher Morgane Besson is seeking to solve the biological mysteries underpinning consumption of these products. Her research raises crucial questions: Are we all equal when it comes to addiction? Does our behavior have a lasting impact on the biology of our brain?
-
Portrait | 2025.03.06
Benoît Chassaing: Harnessing the microbiota to improve health
Ever since he was little, Benoît has always been fascinated by science experiments. He was a "first-generation college student" – no one in his family had been to university before –, and step by step he worked his way up to a career in research.He is a natural-born educator who is passionate about his subject, and he wants science to be open to everyone.
-
Document de presse | 2019.08.12
Cervical cancer: New test enhances ability to predict risk
The Journal of Molecular Diagnostics and the Institut Pasteur report that a new test enhances ability to predict risk of developing cervical cancer in human papillomavirus (HPV)-positive women. This two-fold test is capable of detecting and determining the type of HPV infection as well as the likelihood of progressing to cancer.
-
Portrait | 2025.10.10
Sarah Merkling wants to "pasteurize" mosquitoes!
At the Institut Pasteur, Sarah Merkling's research focuses on a topic that is still largely unknown: interactions between mosquitoes and viruses. She boldly devises novel strategies based on state-of-the-art technologies. Her aim is to combat diseases like dengue and Zika, which are gaining ground and currently represent a threat for more than 50% of the world's population.
-
Portrait | 2026.02.09
Molly Ingersoll: advocating for women's health and women's rights
Molly Ingersoll has been head of a research team at the Institut Pasteur in Paris since 2012. This unfailingly optimistic microbiologist and immunologist is committed to revolutionizing our approach to health. She is currently exploring the differences between women and men in their immune response to disease. The focus of her research is how the symptoms and consequences of urinary infections...
-
Document de presse | 2018.01.26
Olivier Schwartz appointed as Scientific Director of the Institut Pasteur
Professor Olivier Schwartz has been appointed as Scientific Director of the Institut Pasteur on a proposal from the President, Professor Stewart Cole, and following a decision by the Institut Pasteur Board of Directors. He will take office on February 15, 2018. The Institut Pasteur is pleased to announce that Professor Olivier Schwartz has been appointed as its Scientific Director. This...